In addition, we found high levels of wild-type USP2 transcription in couple of B-ALL patients with other MLL subtype (Figures 4A,B), indicating USP2 could also be aberrantly activated in KMT2A rearranged B-ALL. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.